The interactions of various low-molecular weight substances with DNA are naturally relevant mechanisms in the cellular cycle and so also used in medicinal treatment. Depending on the particular drug structure, DNA-binding modes like groove-binding, intercalating and/or stacking, give rise to supramolecular assemblies of the polynucleotides, as well as influence the DNA-protein binding.
I. INTRODUCTION
The idea that molecules can interact in a highly specific manner has a long history in medicinal chemistry. Since Emil Fischer's "lock and key" principle of drug action [1] , a vast number of low-molecularweight drugs with antibiotic [2] [3] [4] , anti-inflammatory [5] [6] [7] , antimeiotic [8] [9] [10] , antimetabolite [11] , antimicrobial [12] [13] [14] [15] antineoplastic [16] [17] [18] , antiseptic [19, 20] , antiviral [21, 22] , cytotoxic [23, 24] , fungicidal [25] , or mitotic [26] potential were investigated. The drugs, which intricate in biological action show a multitude of interaction modes. Different from Fischer's more static lock-and-key description is Koshland's "induced fit" model [27] , which often has been used to describe dynamic processes. The binding of a substrate to the site of the receptor molecule is characterized by mutual interrelations. The substrate itself induces an adaptional reorganization of the receptor and the substrate changes its conformation upon binding. The even though intensively investigated interaction, however are unfortunately not fully understood in all aspects and details until now. However, induced-fit substrate binding might in future be the "flexible key" to control the "adjustable locks" of molecular or supramolecular drug interactions. Once our knowledge represented a level of simplicity that a disease was bacterial, viral or environmentally induced. Recently, we moved beyond that to the internal cell processes and their genomic basis. Modern medicinal therapies could act, for instance, by influencing, modifying and/or replacement of genes. Changes in the genetic structure could be brought about by applying amounts of high-molecular-weight effectors (e.g. enzymes, peptides, oligonucleotides, and their analogous derivatives), as well as low-molecular-weight drugs. Both groups are under investigations in clinical trials. In the present review we limit our introduction and discussion chiefly to the last mentioned topic. "How drugs act and why" is recently reviewed as given in reference [28] .
However, historically most of the drugs have been found by trial-and-error-screenings based among others on the experience with natural products [15, 19, 20, 22, 29] . Chemical modifications in large numbers of the later on isolated relevant species were done for better tolerance and supplementary benefit. General factors affecting the drug interactions may be divided into the following categories: a) structural properties, such as stereoelectronic effects, types of bonding, etc., which found the basis of structure-activity-relationships at the receptorsite; b) physicochemical properties, such as solubility, ionization, partition coefficients and phase behavior; which relate to the drug transport and activity hierarchies from its local application to its site of action; c) spatial characteristics, such as interatomic interaction and complementary fit; d) dose and effective drug concentration, for instance the sphere of action for drugs between powerful, effective, not useful and lethal.
Our focus of this review is on understanding the nature of drugs-binding to nucleic acids (preferentially DNA), both locally restricted and with respect to the general area of interaction. A summary of several diseases cured by nucleic acid/drug interactions is listed in table 1 [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] . Potential mechanisms of action may include immediate DNA complexation, as well as influencing DNA relevant spheres (e.g. biosynthesis). Thereby the nature of the drug molecule has to be pointed out in its necessarily qualifications. An introduction of the drugs will be briefly given in the third chapter. Before, we will describe the current understanding of nucleic acid interactions with their dominant structure-function relationships, including aspects of formations, dynamics and biological implications.
Nucleic acids are biopolymers built up by nucleotides; Fig. (1) . They exist in cells of higher organisms in the nucleus, as well as at the membrane and inside the cytosol. In nature, two forms of nucleic acids (RNA and DNA) differing in the nucleotides (a specific base, a five-membered ribose or deoxyribose sugar, and a phosphate group) are found. In DNA, two polynucleotides form double-stranded helices, whereby the nucleobases are usually connected by Watson-Crick arrangement. These helices are also found in a wide variety of condensed tertiary and quaternary structures in vivo and in vitro [44, 45] . In cells of higher organisms, DNA in chromosomes exists in the repeating nucleosomal arrays that comprise the basic chromatin fibre, condensed as a left-handed superhelix wound around cationic histone protein octamers; Fig. (1) . The tight DNA package makes intrahelical interaction under formation of liquid crystalline phases possible [46] [47] [48] [49] . Changes in the secondary structure lead to organism annihilating as well as protecting mechanisms [50] [51] [52] [53] .
Information transfer from DNA to protein not only requires several kinds of RNA molecules (mRNA, rRNA, tRNA), but also direct interaction was already observed [54] . In biological systems, these processes normally are rigorously stereoselective. Drug-triggered changes therein might proceed chains of reactions involving complex supramolecular structure modi-fications; Fig. (1) [55] [56] [57] [58] [59] .
Further, a serious group of medicines represent a variety of lipids, which could be bound to chromatin and DNA as individual molecules or as lipoproteins. There are among them phospholipids, sphingolipids, cholesterol (and its metabolites) and fatty acids, which can serve also in vivo as signalling molecules [60] . Lipidomics is established recently as a new field of genomics related science and technology (introduced by the authors and co-workers), which deals with lipid composition and function of the cell, including chromatin-and DNA-bound lipids of genome. Structural lipidomics [61, 62] is a branch of lipidomics which deals 
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AIDS viral DNA or RNA docking, HIV-1 secondary structure modification, inhibition of HIV replication [21, 22, [30] [31] [32] Bacteria DNA damaging agents, inhibition of DNA replication, inhibition of RNA replication and transcription, topoisomerase inhibitors, reduction of site-specific recombination [2-7, 12-15, 33-35] Fungi inhibition of RNA replication and transcription, reduction of site-specific recombination [25, 34] Helminth DNA alkylation and restricting of mutagenic properties with non-intercalating compounds [11, 36] Herpes antiviral (see above), photooxidation processes, RNA damage [21, 22, 37] Hepatitis antiviral (see above), reverse transcriptase inhibitors, compounds with activity to supercoiled-DNA, and DNAbinding agents [19] [20] [21] [22] 38] Malaria drugs act by either halting the feeding of the parasite on its host erythrocyte cytosol or repressing nucleic acid synthesis due to intercalation into the parasite's DNA [8] [9] [10] [11] [39] [40] [41] Tumor antineoplastic, single strand break, inhibiting enzyme activity, inducing apoptosis, photooxidation processes, RNA damage, reduction of site-specific recombination [16-18, 23, 24, 26, 37] Radiation (Ionizing) natural genomic DNA-bound lipids are responsible for DNA damage due to the action of ionizing radiation, lipid peroxy radicals induced by ionizing radiation attack DNA moieties which results in DNA breaks [42, 43] with nature and structure of lipids which are bound to other cellular biomacromolecules: proteins, nucleic acids, polysaccharides, membranes etc. (structural, partly, functional), and their complexes as well. It is devoted to the study of specific lipid content/sequence of genomic DNA, structural parameters of lipid molecules in nucleic acids, and also to the study, e.g., of proteome which is a part of DNA supramolecular (nucleic acid/protein/lipid triple) complexes. Functional lipidomics is a branch of lipidomics, which deals with a variety of functions of membrane or cellular lipids and their metabolites (functional, signal, blood-group active, reserve) e.g. participation in signal transduction and gene expression, a mode of function of DNA-bound lipids in genome. Lipids used in medicinal preparations can be responsible for, at least, a part of that functions [62] .
Although decoding of the human genome has been succeeded, but the presence and the decoding of lipids' structure and function in genome is still challenging. It is well established that chromatin and genomic DNA contain neutral lipids and phospholipids [60] . The supramolecular DNA complexes (sc-DNA) formed by binding of natural neutral or phospholipids to DNA were isolated at the first time from rat thymus and liver in 1974, using very gentle phenol-based extraction procedure (for review see [63] ). Similar complexes were obtained from other mammalian cells, tumor cells, bacteria and phages [62, 63] . The data reveal that lipids in sc-DNA complex exist in two fractions: loosely bound (~60 %) and tightly bound (~ 40 %) ones, both being consisted of neutral and phospholipids. Tightly bound lipids, which are bound directly to DNA, are extracted with chloroform/methanol (2:1) mixture after incubation of sc-DNA complex with DNase I treatment for one hour at 37 ºC. Phospholipids from eukaryotic DNA consist of mainly cardiolipin (CL) (40-50 %), phosphatidylethanolamine (PE) (25-30 %), phosphatidylcholine (PC) (15-20 %), phosphatidylserine (PS) (5-7 %), and phosphatidylinositol (PI) (3 %). Sphingomyelin (SM) and phosphatidic acid (PA) are of only traces' amount. These values are quite different from those of nuclear membrane and nuclear matrix where Chol, PC, and SM are the major constituents. Neutral lipids are mostly cholesterol esters (~30 %), fatty acids (~30 %), cholesterol (~20 %), and dyglycerides (~20 %). It is now proved that DNAbound lipid fractions (consisted of lipid molecules containing unsaturated fatty acyl residues) represent the targets for ionizing radiation, and these lipids are responsible for its letal issues, lipid peroxy radicals being formed and DNA molecules being cleaved, as a result [63] . It was also found that DNA-bound lipids are targets for an action of alkylating antitumor agents [64] . [58, 59] ; 5 -tentacle porphyrin [60] .
The structural bases of the complexes described will normally investigated by spectroscopic and crystallographic methods [65] [66] [67] [68] . Nanoscopic techniques (e.g., scanning electron and scanning probe microscopy) are established and improved to visualize and analyze DNA and its complexes [69] [70] [71] [72] . At present, intelligent combinations of all these methods, assisted by molecular modeling simulations, might overcome naive states of our understanding and forward growing insights into the complexities involved.
II. NUCLEIC ACID ACTIVITY
General Aspects
Drug receptors need not be enzymatic or even protein in nature. Nucleic acids, particularly DNA, but also on a growing scale RNA, are prime targets [73] [74] [75] [76] for several major categories of drugs [22] in the areas of infections and cancer (Table 1) . Polynucleotides are well-defined ladders built up by formal addition of nucleotides; Fig. (1) and (2) . The opposite strands are connected horizontally by hydrogen bonding of the nucleobases and vertically by their stacking interactions. The bases are attached to deoxyribose sugar rings, which form, in alternating order with negatively charged phosphate groups, the hydrophilic backbone. The nucleobases are more hydrophobic and have a pronounced tendency to electron-and hydrogen-transfer interactions [77] [78] [79] [80] [81] [82] [83] .
The statics and dynamics of double-stranded nucleic acids depend preferentially on their nucleotide compositions [84] [85] [86] . As quite recently small molecule/RNA interactions are excellently reviewed [87, 88] , our Fig (2) . Survey of different types of double stranded DNA [105] [106] [107] [108] , each side and top viewed; data from crystal structure analysis Nucleic Acid Database Project Rutgers (State University of New Jersey). discussion will focus on DNA. The DNA model derived by Watson and Crick suggested the proper pairing of bases that holds the two strands together. They proposed that only cytosine (C) with guanine (G), and thymine (T) with adenine (A) can pair with each other [89] . However, other hydrogen-bonding patterns have been observed, including base triplets, quartets and reverse base pairs [90] [91] [92] [93] . The stability of connected strands depends on the nature of the hydrogen bonds (usually two or three), the ionic interactions [94] [95] [96] and the base stacking along the strand [97] [98] [99] . Revealed by single crystal analysis, the geometries and energies of several non-standard base pairs are investigated [100] [101] [102] [103] [104] . Generally one cannot assume that the bases always form standard Watson-Crick type, but must consider the other potential types, in equilibrium.
Double stranded DNAs are capable of existing in helices with three main families of polynucleotide structures, displayed in Fig. (2) : A-, B-, and Z-type [102] [103] [104] [105] [106] [107] [108] . To approximate the real conditions, these ideal types have been supplemented with spectra of quite different, energetically and geometrically also possible structures. Their base arrangements differ in the internal parameters, e.g. pitch, tilt, twist, roll, rise, etc. [108] [109] [110] . A-and B-types and their different expressions are right-handed. In contrast Z-DNA is a left-handed variant. The standard structure is that of B-DNA. At normal conditions (pH 7, moderate ionic strength) the helical repeat ranges from 10.0 to 10.5 base pairs per turn with an average rise of 3.4 Å per residue. The A-DNA, which bases are more twisted, and closer packed, applies shorter and broader than the B-DNA [111, 112] . This results from the base pairs being highly inclined relative to the helix axis and a subsequently short rise of only 2.9 Å per base pair. The major groove of the helix is narrower and deeper and the minor groove wider and shallower than found in B-DNA. RNA displays different types of Aform variations.
Furthermore, the structure of a biopolymer is strongly influenced by its surrounding environment [113] [114] [115] [116] [117] . High humidity favors B-DNA, while low humidity, alcohol, and higher salt concentration shift the geometries towards A-and Z-DNA. In vivo, DNA double strands exist in a wide variety of condensed tertiary and quaternary structures, see Fig. (1) . In water the hydrogen bonds between the bases must compete with those to water. Sequence-dependent anisotropic flexibility could influence perpendicularly directed mini-kinks [118, 119] . DNAalkylation is described as an anomaly that enhances the curvature of the polynucleotide, too [120, 121] . The natural curvature of the helix is important for protein/ DNA interaction [122] . Depending on ionic conditions, intra-and intermolecular interactions deter-mine the corresponding static and dynamic of the systems. Recently, lipid/ DNA interactions are under discussion in the field of functional genomics [60, 62, 74] . While so far the stereoelectronic patterns of DNA are biologically involved in many relevant reactions, changes in them are of crucial importance in mutagenesis and ageing [60, 63, 121] , as well as in cancer, inoculation, and hereditary diseases [123] .
Binding Modes
Intercalation
The intercalating drugs are a large group of compounds with various kinds of structures, but all combining planar aromatic chromophores (important structure units of common intercalators, see Fig. (3) ). These planar polycyclic tracts are capable of horizontal "sliding" into the interstacked gap of the DNA receptor helix between the base pairs [124] [125] [126] . Charge-transfer forces, hydrogen bonds, hydrophobic and sometimes also electrostatic interactions would hold the drug in [127] , whereby, aromatic charge-transfers between the chromophore and the bases often display essential stabilizing factors. This process, called intercalation, interferes with normal DNA function (like transcription, replication) and therefore imparts pharmaceutical properties to drugs capable of intercalating.
Intercalation can either kink or bend the DNA, unstacking one or more adjacent base pairs together with locally lengthening and unwinding the DNA. The drug presence also influences the situation at the nucleic acid over long distances [128, 129] . Lerman first postulated the intercalation model for complexes of native DNA with acridine derivatives [75] . Later on Hendry et al. [130] and Hoffmann et al. [22, 82, 131] extended different base pair conceptions to a large number of existing and foreseeable intercalators. Generally, physicochemical criteria of DNA intercalation are as following: the increase in the contour length of duplex DNA; the stabilization of duplex DNA in the complexes; changes in chiral properties of DNA; unwinding of supercoils from natural supercoiled covalently closed duplex DNA with ligands. The determination of changes in the spectral properties of bounded ligands is a major observation expedient for DNA-intercalating agents [69] .
Varying side-chains of the chromophores results in different intercalating molecules improving or deteriorating the molecular recognition. Complex intercalators like actinomycin [132] , daunomycin and their derivatives contain sugar-and (depsi)peptide-like tracts in their structure; Fig. (4) . This offers additional interaction [133] [134] [135] . Exemplarily this would be introduced with daunomycin. Crystal structure analysis in Fig. ( 5) [56] shows that the chromophore inserts "head on" between the bases while the aglycon fits to the minor groove [137] . However, mono-intercalators have a limited sequence specificity founded in the direct interactions between only two base pairs.
This schematic recognition is principally deputy for most of the other intercalating drugs and their derivatives. In a B-DNA, the space between the hydrophilic backbones is approximately 10 Å. Most of the used intercalating drugs display a 3-cycle chromophore in their structure. Because of the geometrical overlap, the intercalation of 3-ring-cycles, with a diameter of around 7 Å, seems to be preferred compared with the intercalation of 2-ring-cycles (5 Å) or larger ones. Based on this principle, drug/base pair conceptions were developed which take the DNA morphology into their consideration. [72, 130, 131, [138] [139] [140] . The adaptation could be increased with side chains added terminally to the oligocycles. Additional interrelations inside the grooves and backbone fitting properties are useful. Here, sugarresidues, (depsi)peptide-like and other hydrogen-bonding structures, mono-and bis-laterally attached to the side the drug molecules would increase the facilities of interactions. The combination of intercalating structures linked with flexible (privileged with peptide-units) chains of appropriate length, allows bis-, tris-and oligointercalation into DNA [22, 142] . This might increase strongly the sequence specificity of intercalating drugs [143, 144] . Intra-and intermolecular connections of the DNA double strands in supercoiled formations are also possible [66, 145, 203] .
Most of the drugs intercalate in alternating sequences. To overcome the unfortunately poor selection between A/T and G/C tracts, drugs with enhanced DNA affinity and sequence discrimination are currently under investigation. The alternating purine-pyrimidine sequences are frequent in the human genome and they simultaneously confer an extreme conformational variability on DNA. The base pairs are able of twisting, tilting and shifting, accommodating with drug stacking and conformation changes [145, 146] . They differ from homologous sequences in characteristic properties, e.g. the premelting [147, 148] . Homologous A/T-tracts often produce a sequence-derived macroscopic curvature in DNA [148, 149] . In addition to the normal Watson-Crick connection, homologous sequences display non-coplanar regions developed from further feasible non-Watson-Crick hydrogen bonds diagonally across the major groove. The bases are twisted and the double strand will be stabilized by this interaction (for homologous (dA)·(dT) and (dG)·(dC) structure see [150, 151] ). Intercalation into homologous sequences therefore seems to be hindered.
In nucleic acid research, various analysis methods are based on changes in the properties of nucleic acids and ligands during intercalation. These include the fluorescent determination of nucleic acid structures and quantities; fluorescent assays of activities of various enzymes involved in nucleic acid metabolism; chromosome identification according to their fluorescent binding patterns; separation of nucleic acid topological forms, and many other techniques. The inhibition of DNA regulations represents an important consequence of DNA structure modification due to intercalation. Druginfluences in replication, transcription, protein/ recognition, and biopolymer-degradation are inserts into networks of interrelating processes.
Even though there exists a considerable pharmacological potential of intercalating drugs and their main efficacy is devoted to, antiviral, antibiotic and immunmodulatory effects [145, 153, 154] . Only a limited number of intercalators (acridine types) are used as antitumor drugs [155] [156] [157] . [56] ; data from crystal structure analysis Nucleic Acid Database Project Rutgers (State University of New Jersey).
Groove Binding
The two grooves of the B-DNA double helix offer highly differentiated and to a certain degree even flexible potential receptor sites for crescent-shaped drugs complementarily mimicking the shape of the helix [152, [158] [159] [160] . Modeling the more unspecific introductory contacts of proteins within the minor and their comparatively specific reading of nucleic acids codes within the major groove, small molecule effectors might profit from hydrophilic contacts to the outside sugars and phosphates, and likewise more specific hydrogen-bond highlighted hydrophobic interactions with the inside bases. The optimization of the statics and dynamics of stereoelectronic fit between drug and nucleic acid receptors will forward the development of more specific drugs.
In living organisms, the reading of sequence information on DNA involves binding of proteins to specific control regions of the genes (an overview of the gene regulatory interactions is given by Shakked et al. [161] ). Here groove-binding molecules that choose sequence selectively those recognition sites are of major interest. Whereas the major groove often is occupied by the highly specific recognition patterns of the protein interactions, the more unspecific contacts with the minor groove could additionally be utilized for drug targeting. Small groove-binding species (selection see Fig. (6) ) have shown a wide range of biological activity from antitumor to antiviral, antifungal and antimicrobial effects [133] . Their modes of action in all cases involve initial groove binding, followed by interference in the functions of DNA regulations, e.g. replication and transcription factor binding [162] [163] [164] .
Even though most of the DNA binding drugs interact in the minor groove, the major groove might be not only useful to support the minor groove interaction, e.g. with electrostatic interactions of water molecules and counterions. Within the common protein/DNA recognition a key component of gene regulation is the binding of transcription factors to promoter elements containing their consensus DNA binding sites. These proteins exploit all at the beginning mentioned modes of binding to specific control regions of the genes: Intercalation or partial insertion of aromatic units, binding of α-helices into the major, and binding of loops of polypeptide chains or β-sheets into the minor groove. A promising goal in drug research is the imitation of the protein recognition with its strong-selective interactions. However, until now no drug application could act like nature.
Still, by investigating the major groove, several binders are already developed [165] [166] [167] . Almost all of these drugs are less-likely to interfere with generegulatory proteins [168, 169] . In fact drug efficacies, like DNA damage, as well as inhibiting the transcription and/or replication are often found [170] . Porphyrins, for instance, are excellent partners for this kind of DNA interaction [60, 138, 171, 172] . The electron-rich porphyrin ring system is able to form charge-transfer complexes in the grooves, also if a metal atom occupies the center. Likewise, intercalation and DNA damage by oxidation processes are described [173] [174] [175] . Cancer therapies with porphyrins as photosensitizing agents take advantage of this [176] . However, because of the structure of porphyrin molecules, the interaction in the major groove seems to be privileged. Lipscomb et al. described the first crystal structure analysis of a porphyrin-DNA complex for a water-soluble tentacle porphyrin [60] . Besides the classical major groove binding, porphyrin molecules are able to pile up by self-assembly and bind in stacking formation (see also chapter 3.1 and 3.2).
As described above, the more important target for drug interaction is the minor groove. Their width depends on the primary and secondary structure. A/T rich tracts in a B-DNA, with their rather narrow distance of 9 to 10.5 Å, would bind preferentially drug molecules with imidazole and pyrrole units, which mimic the structure of distamycin and/or netropsin [177] [178] [179] ; structure see 7). The negative electro-static potential of A/T sequences suggests that the minor groove site is a likely target for positively charged ligands [180] [181] [182] [183] . Hydrogen bonds between drug and the DNA contribute to the interaction. The diversity of drugs interacting in the minor groove of DNA is reviewed in literature [133] .
The strongly developed AT selectivity of minor groove drugs could in part be explained by the "more occupied" groove of GC-rich sequences. In particular, the sequence dependent groove width, and the receptor patterns of the hydrogen bonds are assessed within structure-activity relationships. However, imidazolecontaining analogues of netropsin probably induced a preference to GC rich tracts. Conjugated to coumarin or psoralen, these new agents demonstrate marked photoinduced stereoselective cytotoxicity [184] . As another agent, mithramycin, is well established as GC binding drug with a satisfactory selectivity [185] [186] [187] . There a bridge between protein recognition potentials and (bio) chemical drug modifications was functionally developed. interactions involved in drug/DNA recognition were characterized, supported by specific triplex formation of the aptamers [169] .
Polyamides, built up by (hydroxy)pyrrole and imidazole amino acids binding A/T specific, form hairpin-structures and could discriminate between A/T and T/A base succession [188] . This provides a basis of drug development by increasing their sequence selectivity. The associated recognition in the both grooves by much smaller synthetic ligands is also under investigations [189] . By the formation of triple helical complexes, it is well known, that oligonucleotides can selectively recognize oligopurine·oligopyrimidine tracts. Under imitation of this process, well-known minor groove binding drugs (e.g. distamycin and netropsin) are modified. For instance, the replacing of pyrrole rings by imidazole provided a recognition element for guanine [190] . A recent overview of oligonucleotide aptamers, designed to recognize small molecules, is given by Famulok [191] . A topical example is described by Bruice and coworkers [192] [193] [194] . They have developed a family of compounds that bind to A/T regions of the DNA minor groove and are able to recognize adjacent guanosines. Here, pyrrole-containing peptides are combined over carboxyl termini with dimethylamine substituents, which bind to the negatively charged backbone. Addition interactions are reached by triple-helix formation with linked oligonucleosides in the major groove. This clamping effect increases the binding constants and results in bending of the DNA.
Miscellaneous DNA/Interaction; Stacking, Cross-Linkage, Cleaving, Alkylation and Damage
Sweeping structural transitions, induced by drug treatment, are real, often found phenomena. Electrostatic influence (by drugs) and negative supercoiling, analogous to increasing temperatures, destabilize the stacking and pairing of the bases and induce local distortions of the DNA. Far-reaching interactions could produce the partial or total cleaving of the strands. Intra-or intermolecular strand-interrelations could influence circumferentially wrapped DNA into toroidal formations [195] . Multivalent counterions are well-known agents, which act in this manner [196] [197] [198] . The DNA supercoiling plays a fundamental role in the cell [45, 145] . Hamiche et al. describe that during the transition the histone neither dissociate from the DNA, nor were even significantly reshuffled [199] . Therefore it is of marked evidence, if backbone-interaction, drug stacking, strand cross-linkage, Fig. (7) . Crystal structures of netropsin interacting as groove binder in the minor groove of AT rich DNA [178, 179] ; data from crystal structure analysis Nucleic Acid Database Project Rutgers (State University of New Jersey).
and particularly inter-and intrastrand interactions promote the secondary structure, as well as the tertiary and quaternary, too.
Stacking as well as cross-linkage over the two strands, are often employed drug interactions. Drug-drug interaction influences the association of other molecules. Cross-linkages and backbone-interactions promote the binding affinity. Biological processes take advantages of the complex interaction facilities of the DNA [28, 43, 197, 200] .
As described above, some ligands (e.g. porphyrins) are able to form self-assembled structures, which could interact with the double helix. More than likewise groove interactions, stacking interactions are influenced by the backbones. The negatively charged phosphate groups and the chiral sugar residues influence the binding in a direct manner. The polynucleotides, built-up by stacked base pairs linked with sugar-phosphate groups, could behave as matrices for stacking interactions, which support the formation of pile up structures. The interactions range from pile-up of single molecules up to the polycondensation of amide-containing systems and PNA structural elements, yielding comb-like keys for recognizing the DNA shape. Single molecules interacting in the described behavior are, for instance, porphyrins, phthalocyanines, and other polycycles with a conjugated π-electron system, as well as derived surfactants and lipids (see also chapter 2.3.). The last ones are currently under study as promising agents in antiviral therapies against influenza [201] .
Local DNA-cleavers interact, within their introductory steps, in a similar way like intercalators or groove binders. Different from the stabilizing interactions, these drugs would interact with the strands by weakening the H-bonds of the bases. Thereby the drug itself can bind to one strand and slide between the bases. For instance, Bleomycin and derivatives could represent as DNAcleavers [202] . They take an effect on the minor groove by blocking and/or disturbing the receptor site. Porphyrins at low-ionic conditions can interact faced-on in the major groove. This binding strongly influences the stability of the double strands [175, 203, 204] . At high salt conditions, the same molecules are able to aggregate in self-assembled stacks loaded on the DNA [205] . This behavior, tested for metal containing as well as metal-free porphyrins, was also found for chlorophyll/DNA complexes [175] . Chlorophylls, each containing a central Mg 2+ -cation, bind directly to the phosphate backbone. In a complex reaction course the Mg-nucleobase interactions follow up to occurrence of a partial helix opening.
Ligands forming DNA adducts, could also be able to damage the DNA by oxidative or reductive processes [206] . Schematically, the mechanism commences with a process, for which backbone interaction, as well as intercalating or groove binding recognition would be used. Additionally, groups forming irreversible reactions injure parts of the DNA. Both interactions, stabilizing and destabilizing the double strands, are studied. The structural modifications take an overall influence spread over the cellular processes. So this, in particular the development of DNA-adducts influencing the protein/DNA binding, are promising research directions.
By the view of drug benefit in medicinal therapies, the sight of general structural transitions, with sometimes unintended drug interactions, should not be ignored. Desirable drug binding has to be selective enough to avoid side effects. That's why DNA cleavage and damage is a critical seen interaction, which has to be handed under force control to avoid unfavorable mutagenesis [26, 28, 207] .
Chromatin-and DNA-Bound Lipids
Studies with synthetic DNA polynucleotides reveal that neutral lipids; oleic acid and cholesterol can be bound to DNA double helix tightly, oleic acid being involved in binding, likely, to minor groove [61, 62] . The interaction of synthetic polynucleotide double strands with a natural lipid -e.g. oleic acid -was examined in diluted aqueous solutions with defined double and triple stranded oligo-and polydeoxyribonucleotides. Whereas duplexes are influenced by oleic acid ligandation, which could not be removed by dialysis, no binding occurs to triple stranded DNA. The results indicate that oleic acid shows molecular recognition to AT base pair motifs by groove binding. GC tracks -in particular, alternating d(G-C)_d(G-C) motifs -are strongly influenced by ligand interaction up to a ratio of one lipid molecule per two base pairs. Likewise, the spectroscopic and morphological changes in the supramolecular association of the complexes after treatment occur even after dialysis procedure. Additionally, monolayers of biotinylated DNA duplexes were immobilized on a streptavidin sensor-layer for surface plasmon resonance observations. Small portions of the ligand were injected in continuous flow. Loosely bound molecules were removed by washing procedure. Injections of sodium hydroxide denature the DNA, releasing the tightly bound effectors. The amount of tightly bound oleic acid molecules was determined at one molecule per 2-3 base pairs. As a consequence, a new mechanism of regulation of gene expression at nuclear membrane or by lipids inside DNA double helix has to be discussed. It could be suggested that fatty acid (oleic acid) binding to d(GC) tracks in "exhaustive" type represents a possible mechanism for a stabilization of GC-dinucleotides repeats in non-coding areas of human genome. Recognition mode for oleic acid -poly d(A).poly d(T) suggests, likely, fatty acid molecule binding to minor groove, which is more hydrophobic, because of thymidine methyl groups are exposed to a minor groove in the case of poly d(A).poly d(T). For details please use [62] .
The latter phenomenon follows also from computer modelling experiments of DNA/C18 fatty acids complexes. Calculated binding energy values appear to be higher for linoleic acid than for oleic and linolenic acids, oleic acid being "bumerang" shaped, which is important for ligandion to a minor groove. Computer modelling and molecular mechanics approaches are applied to clarify DNA-phospholipid recognition pheno-menon. Values of binding energy are calculated using molecular mechanics and docking approaoches for an interaction between all 64 oligonucleotides of genetic code -ApApNpNpNpApA and phosphatidylcholine (PC) or sphingomyeline (SM) without or in the presence of magnesium ions [208] .
Consequently, the synopsis from biophysical and computer experiments are the following: i) complexes between phospholipids and GC-reach triplets are characterised with highest binding energy values; ii) binding energy value is higher for SM complexes than for PC ones; iii)complexes are more stable for triple -DNA, magnesium ions and lipid -complexation, than for complexe without metal ions; iv) Fatty acid molecules could be bound to DNA minor groove with a high energy gain compairing to binding to major groove; v) the spectroscopic results indicate that oleic acid shows molecular recognition to AT motifs by groove binding; vi) GC tracts are characterized with "exhaustive" type of ligand binding up to a ratio of one molecule per one base pairs.
In conclusion, chromatin DNA-bound lipids represent an established phenomenon and, being low molecular mass compunds and be bound to the DNA minor groove, could be considered (at least tightly DNA bound lipid fraction) even as an integral part of genome, in a contrast to non-histone acidic proteins, transcription factors, etc, which represent biomacromolecules and bound to the DNA major groove. Up to now, we can present only average content of DNA-bound lipids in chromatin/ genome, but not specific sequence of these "genomic" lipids, so called DNA-lipid code. The DNA-lipid code could not exist, and chromatin DNA-bound lipids can exist (especially, loosely DNA-bound lipid fraction) in a form of DNA-bound lipoproteins, anyway a new type of biomacromolecular complexes -triple nucleic acid/lipid/ protein complexes -being formed.
III. DRUGS
After a long period of empirical drug discoveries, now some general features of the drugs seem to allow the development of potent representatives for DNA interactions by chemical and genomic methods [4, 21, 209] . A desired drug has to combine within its structure quite different characteristics. It will be concerned with polar solvents such as water and non-polar and/or amphiphilic solvents such as lipids. Hybrid structures containing electron/proton donor/acceptor groups, and by this able to perform charge-transfer interactions and electrostatic bonds, were demonstrated to be not useless. Also it is necessary to include stereochemical considerations in the expectancy of a new drug. Computer modeling systems are currently competing for optimizing stereoelectronic and structural approaches. The approximation profits from the strong increase of obtainable data, as well as the increasing calculation power.
Most of the following statements are generally valid for bioactive drugs. In this review we diminish the list of properties on nucleic acid/drug interaction preconditions.
Drug structure
Generally, the drug structures can be classified in the following manner, whereby the classes are not exclusive: a) Electron-rich u nits with an extensive conjugated π -system . Electron-transfer interaction with the bases of the DNA will be facilitated (e.g., intercalation, cleavage and/or single strand binding; antiviral).
b) Crescent-shape structure with peripheral H-bond contributions . This supports interactions in the grooves of the double strands (e.g., helical fit; block of the receptor site).
c) Multivalent ions. They disturb the stereoelectronic interactions of the biomolecules and induce condensation processes (e.g., inducing cross-links, circumferentially structure transitions; antineoplastic).
d) Natural products with a complicated frequently chiral structure . They should interact selectively dependent on their complementary stereoelectronic fit (e.g., high specific recognition; antibiotic).
Most of the powerful drugs combine these features or some of them in their structure (Fig. (3) , (4) and (6)). In the following examples the principles of typical drug structures are illustrated in the light of recent investigations. Delocalized π-electrons in two (naphthalene basis), three (anthracene frame) or more combined ring systems connected with electron/proton accepting or donating group serve a first request on a drug [130, 159, 210, 211] . When it follows the line of the helix, the bends on a crescent structure have a favorable effect on the binding in a DNA groove [133] . Multivalent drugs, which lead the DNA to intramolecular structural changes, e.g. by bridging long distant tracts of the polynucleotide, are able to induce special conditions for sweeping phase transitions up to condensation-based collapse [145] . Changes in the organized three-dimensional structure, selectively induced by drugs, are an often-observed phenomenon [212, 213] (see also chapter IV).
Netropsin, distamycin, and berenil are wellestablished small molecules (Fig. (6) ) binding in the minor groove of the DNA double helix (see chapter 2) [214] . In order to bind effectively, the structures of these compounds and their effective derivatives follow the structural and energetical contours of the groove by optimizing favorable and minimizing unfavorable contacts; Fig. (6) and (7) . They often contain a series of linked aromatic ring systems, which are close to coplanar when viewed from the side. Resonance and inductive effects of the NH2-C= + NH2 structure elements pronounce the electronic effects of the conjugated ring-systems, and could induce interchanges with the receptor-site.
Structure modifications of small natural molecules, which specifically bind to any unique DNA sequence, would be useful tools in biological chemistry and potentially in medicinal therapy [74, 133] . The natural product distamycin has provided a frequently used starting point for different designs of such molecules. Distamycin preferentially binds in the DNA minor groove at stretches of A/T base pairs, with the 1:1 ligand:DNA complexes extending over four base pairs [169] . The structure contains a series of N-methylpyrrole rings linked with peptide-like groups.
However, until recently attempts to create a general design for small molecules that bind designated DNA sequences had limited success. In the literature, imidazoles are described as promising agents, which might interact also in combination with different groove binders and/or intercalators under exploitation of their benefits. Recently, polyamides with 2-methyl-imidazole and N-methylpyrrole amides are developed, which bind specifically in the minor groove. An imidazole on one ligand complemented by a pyrrole on the second ligand recognizes a G/C base pair, while a pyrrole/imidazole combination targets a C/G base pair. A pyrrole/pyrrole pair was degenerated for A/T and T/A base pairs. Depending on the widening of the groove, side-by-side 2:1 complexes containing 5 and 6 base pairs (comprising both G/C and A/T base pairs) were observed [215] [216] [217] [218] .
Physicochemical properties
Physicochemical properties such as solubility, partition coefficients, and ionization, relate to the drug transport from application to its site of action. At temperatures normally encountered in living matter, strong bonds are not likely to be broken by nonenzymatic means. The majority of drugs designed to affect physiological functions do not react by the formation of irreversible covalent bonds with receptors or various biopolymers in our systems. Those that do are usually very toxic, long acting, and difficult to control safely from a clinical standpoint. Drugs acting much weaker in a thermodynamical balance "by a chemistry beyond the covalent bond" [219] are much more desirable.
Unfortunately drugs intended to rid the body of disease-causing parasites, as well as anti-tumor agents, so far are preferably those that interact covalently and irreversible. The problem of the selective toxicity will be solved by disguise of the drug molecule until its arrival at the active site. With structure elements, as sugar-like, lipid-like, or surfactant compound the solubility in hydrophobic and hydrophilic solvents can be controlled by chemical intervention [201, 206, [220] [221] [222] . Since most drugs are not structurally similar to normal cellular components, they are not likely to be transported across the membranes by "active transport" mechanisms. In combinatorial chemistry, a promising goal is to couple the drug (or effective units) with viral vectors, lipids or transport proteins [201] . Peptide-like structural units, included inside the structure, might couple reversibly with endogenous molecules and will be released after membrane passage. The partition coefficients are complex functions of the underlying phases and microphases.
Some chemotherapies use the different properties of cells to control and direct the drug interaction. On the one hand, the increased metabolism of tumor cells requires an adequate influx for substances, what facilitates the drug resorbance. On the other hand, tumor cells still have a lower pH value than normal tissues. Taking advantage of this, this could control some drug accumulation in cells. For instance, HpD (photodynamic agent hematoporphyrin IX derivatives, registered trade mark Photofrin II) kills selectively tumor cells while leaving normal tissues relatively unaffected [223, 224] . Also it was found that HpD in aqueous solution precipitate at pH <7. Simple physicochemical differences between the tumor cells and others may explain the cancer selectivity of HpD. When HpD enters the tumor cell it accumulates inside, while in other cells the drug usually leaves the tissue after a certain time period. HpD molecules, as chiral porphyrins, were found to selfassemble at concentration >0.25 µM in a pile-up structure [227] . This, triggered by the stereochemical effort of the single molecules, can result in a left-handed or right-handed helix, strongly influenced by temperature and pH conditions. Continue doing, HpD impacts inside the cell by interaction at the membrane of the nucleus. It is known as enhancing irradiation effects in cancer cells by reducing the energy supply, leading to an irreversible inhibition of DNA repair, increased cytogenetic damage and cell death [225] . Singlet oxygen is believed to be the proximate reactive species generated by porphyrin illumination. Because this molecule reacts with almost every cellular constituent, the way that singlet oxygen or its reactive oxygen species by-products trigger apoptosis remains to be elucidated [226] . Scanning Force Micro-scopy (SFM) observation after drug action in affected tumor cells nicely shows the self-assembled helical structure of HpD within the tissue. Examples are given in Fig. (8) . The membrane is destroyed. In comparison, SFMinvestigations of untreated tumor cells are shown. [228] . Still, in some tissues the cancer activity of HpD is less. So, lung tumor cells treated with HpD survive to a great extent. They, proven more resistant against oxidation processes, resist the damage by singlet oxygen and might unfortunately prevent the accumulation and/or selfassembly of the drug [228, 229] .
Spatial Characteristics
Chiral specificity of nucleic acids is evident for ligand discrimination. Moreover, chiral ligands are useful agents for selective site recognition, because their spatial chiral informations could interfere with enantioselective effects, like in terms of the macromolecular crowding [212] . This well known for macromolecules, like proteins or DNA, is also valid for much smaller drug molecules [230] [231] [232] [233] [234] . There are different reasons causing optical activity in drugs and their complexes. First, there are stereochemical properties like R/S-carbon atoms, cis/trans vinyl groups, syn/anti conformations, etc. in the molecular structure. Second: left/right handed helical formations, macromolecular folding and coiling, until even highly organized toroid or crown structures with different indentpatterns could be important in a three dimensional view. Chirality, isosteric and tautomeric phenomena can be varied by the design of a drug molecule.
Self-assembled helical structures built-up by drugs or drug-complexes show a strong interdependence to their activity. Not only the above discussed porphyrin molecules [227] are able to display such phenomena.
There are many other molecules and multi-component systems acting in the same course. For instance, an enantiomerically pure three-component system of a bile salt or a nonionic detergent, a phosphatidylcholine or a fatty acid, and a steroid analog of cholesterol, was found to self-assemble in helical ribbons, and interact as drugs in a high-specific way [235] . Highly organized nanotubular structures are designed to facilitate the transport through the membranes. They have to mimic the lipid tubule formations and could transport drug molecules within [236, 237] .
Furthermore, liquid-crystalline phase building is an often-found phenomenon in cells and also in selfassembled structures. In so called mesophases, intermolecular interaction over a long range induces an overall structural formation [43] . DNA itself is able to form liquid crystalline phases in condensed solutions. Strong polyelectrolyte interactions between the helices control the phase transitions, reaching from nematic, and cholesteric, to smectic and columnar patterns [238, 239] . The features of the different interhelical arrangements suggest that these effects observed in concentrated biopolymer systems will have broad applications in biological mechanisms [116, 131, 240, 241] . Cationic agents complexed to DNA often interact through interhelical packing regimes, which benefit from mesophase transitions [48, 195, 197, 242] . For instance, Wolf et al. describe the protective mechanism of DNAbiocrystallization in cells [53] . For virtual drug modeling the informations of the receptor site could be used as template. Under consideration of electronic distribution patterns, the modification of well-known drugs with desired properties determines important aspects of structure-function relationship.
Modified monosaccharides are studied for induction of selective anti-proliferative processes. Recently, some of their analogs are developed, which under stereoselective interactions selectively inhibit tumor cells in preference to normal cells [243] . Other promising agents are the so-called "mirror-image" RNA aptamers. They are oligonucleotides with sugars in the enantiomeric L-form [244] . The use as high-affined nucleic acid representatives for the so far known monoclonal protein antibodies in medicinal therapies is under investigations.
Besides the stereochemical precondition in the molecular structure (R/S, cis/trans), changeable spatial characteristics in the three dimensional arrangement of drugs are of interest. This will be exemplarily discussed in case of the different conformation equilibriums of sugar rings and their base and phosphate connections. Fixed sugar ring puckers of modified nucleotides on a bicyclo-template show a rigid selectivity of the "Northern" and "Southern" conformation. In aqueous solution, the sugars exhibit a rapid dynamic transition between the two forms. However, particularly the "Northern" form reveals an expressed antiherpetic potential [245] . Cyclooligosaccharide analogues, where six hexopyranose residues are linked together by ether groups in a macrocycle, demonstrate a similar behavior. Within a dynamic equilibrium the macrocyclic conformation changes between three shapes [246] .
Those ligand-induced structural changes might in future be used as a general template for selective drug interaction. Adapting different geometries to appropriate guest -in an overall dynamic process -corresponds more closely to Koshland's induced-fit mode [27, 247, 248] of substrate-receptor interaction than to the more static lockand-key model [1, 249, 250] . The exploitation of spatial characteristics in drug development is a prospective objective for further investigations.
IV. BINDING MODES IN COMBINATION WITH SUPRAMOLECULAR INSIGHTS
However, the drugs usually don't act exclusively on nucleic acids, but also upon other biopolymeric compounds inside the organisms (e.g. proteins, membranes). Polyfunctional drugs, that are able to interact with DNA, are suspected to stimulate further favorable and unfavorable interactions [251, 252] . Applied with satisfactory precaution in combinations, they are promising to surmount drug resistance difficulties [253] [254] [255] . Multiple interaction modes could be illustrated exemplarily in the short discussion of the following examples.
Anthracycline and its derivatives are relevant chemotherapeutics. At present, they are some of the most used antitumor drugs that interact with DNA, still with drug-resistance appearances [256] . In their structure (Fig.  (3) ), they all contain an electron rich quinone ring system in the center of the molecule, which mode of operation depends on electron-transfer reactions [257] . Thereby, one or two electrons can reduce the quinone ring. The resulting species can react with present oxygen to give superoxide anions (O2 ·+ ) and ultimately molecular oxygen and hydrogen peroxide. These molecules are cytotoxic in DNA damage. Local intercalations of the flat quinones between the bases concentrate the DNA damage highly effective. Additionally, several enzymes are inhibited by anthracyclines [258] . Interactions with intracellular signaling pathways and oxidative stress are thus the key reactions in anthracycline-mediated apoptosis [157] .
Hoechst33258 also has been used as the starting point for a number of rational drug design studies aimed at altering the biological activity and/or sequence selectivity of the drug [259] . An overview of the structural modification is given in Fig. (9) . Hoechst33258 contains two benzimidazole rings in the center, connected with a 4-methyl-1-piperazinyl and a 4-hydroxyphenyl ring. The inner-facing nitrogen atoms on each benzimidazole group are described as bind to pairs of O2/O2 (thymine/ thymine) or (O2/N3) (thymine/adenine) base edge atoms [111, 260] .
In the presence of A/T-rich polynucleotides, Hoechst33258 is described as a minor groove binder, while in G/C rich sequences (more than 60 %) it shows intercalation [261, 262] . With the exception of the first analogue, all so far synthesized further derivatives of Hoechst33258 show decreasing potential to act as DNAligands; Fig. (9) [140, 181, 263, 264] . Some of them could interact in the minor groove independently of the sequence without intercalating attitudes. Others intercalate exclusively in various sequences without showing groove binding behavior. Moving the OH-group of Hoechst 33258 from para to meta position (see metaHoechst33258) results in additional hydrogen bonding during groove binding in G/C rich sequences. NMR data show that the hydroxyl group points directly inside the groove [265] . N-alkoxyalkylation (structure not shown) at one of the benzimidazole groups of Hoechst33258 (directed away from the minor groove) has only a minor effect on the binding, while N-alkoxyalkylation (directed towards the minor groove) diminishes the DNAligandation [266] . However, intercalation between G/C Frontiers in Medicinal Chemistry, 2004, Vol. 1 Bischoff et al.
Fig. (9).
Chemical structures of Hoechst33258 and derivatives [140, 181, [261] [262] [263] [264] [265] [266] . bases was markedly prevented by suitably designed additional side-chains. These miscellaneous interactionaspects of Hoechst33258 and its analogues demonstrate the variability of drug within biological systems.
Competitive drug binding in a DNA/protein complex could be successfully reached with the marine natural product ecteinascidin (Fig. (4) ) and some of its derivatives [267] . The anti-proliferative activity was found to be greater than that of several antitumor agents by 1-3 orders of magnitude. While ecteinascidin is reported as a minor groove binder and guanine-specific alkylating agent, the mechanism of action induces DNA/protein binding via cross-linkage [268] . DNA alkylation alone mostly seems to be insufficient for the expression of significant cytotoxic activity. The DNAprotein cross-linkage by drug, on the other hand, is likely to produce sufficiently serious DNA damage to generate an effective cell death signal [269] .
Supramolecular Relationship
The spatial structure of duplex DNA is known to undergo significant changes in response to a wide variety of environmental perturbations [121] . Hydration is assumed to contribute significantly in the regulation of drug binding and discrimination. Ion induced transitions are involved in both local and long-range changes, including the helical repeat, as well as the torsional and bending rigidity. This could also take place in the presence of ionic drugs [270] [271] [272] . Electrostatic attraction and repulsion must be adjusted to allow a cooperative accommodation within a network of hydrogen bonds and dipole interactions [197, 233, 273, 274] . Based on the "induced-fit" draft, a complex supramolecular associated model seems to be emerging, which involves the variety of interrelated drug-bindings with their interaction at the active sites. The new aspects are that the nature of the complex is not fixed but determined by dynamic environmental conditions. Interactions, such as water activity, modulate the energetic barrier at the side of helix conformation changes. Networks of extremely sensitive and vice-versa tuned complex transitions are involved in the regulation of cellular processes [121, [275] [276] [277] .
Since mutation avoidance and DNA mismatch repair play a crucial role in cancer chemotherapy, a promising idea in medicinal therapy is to study the influences in the formation of micronuclei at selected genes (e.g. oncogenes), inducing apoptosis or cytotoxic effects. The number and position of micronuclei in the human genotype normally is a characterizing mark for each individual. However, mitotic arrest and micronuclei formation often were parallelly observed. Some informations of recent research point out to a conjunction of curved DNA and the micronuclei inducement. Proteins, which are able to bind to curved DNA, strongly influence the number of micronuclei-like structures [278] . Abnormalities by accumulating cells during the cell division cause either micronucleus formations, chromosomal aberrations and/or aneuploidy. On the other hand, existing micronuclei influence the division, among others, by p53 interaction [279] . Genotype interactions of the drugs also sometimes result in increased frequencies of appearance of micronuclei [280, 281] . So it is not astonishing that chromosomal aberrations and micronuclei formation in cells are of increasing interest also in the development of new drugs and drug-therapies. Their influences on the secondary DNA structure (e.g. curvature inducement) to the formation of micronuclei in cells [282] [283] [284] seems to enter a key position in the structurefunction relationship of cancer therapies [50, 279, 285] .
Some paving stones are already collected. In experimental systems, mismatch-repair-deficient cells are highly tolerant towards methylating chemotherapeutic drugs, and however to a less extent, to cisplatin and doxorubicin [286] . The first group of drugs is therefore expected to be less effective on mismatch-repair-deficient tumors. While the mismatch repair status becomes an important determinant in the choice of pharmaceutical cell intervention, the significance of DNA structural changes remains to be investigated in details.
The tight DNA package in the nucleus makes intrahelical interactions possible. Special states between the ordered structure of a crystal and the rather disordered isotropic phase are represented by the intermediate order of "mesophases" of liquid crystals. DNA itself has been shown to form liquid-crystalline phases at high concentrations [238, 239] . As a whole, one can suggest that high-affinity ligands targeting the highly conserved coiled-coil surface, particularly its cavity, will have broad activity against several viral and genetic diseases and are less likely to be by-passed by drug-escape mutants. Much current activity in drug development depends on this topic. In the following discussion some common drugs will be described in their supramolecular interaction area.
In a more recent conception, a coil-coil interaction bridged by a definite cationic drug that transforms the extended DNA conformation to compact structures is described. A schematic introduction is presented in Fig.  (10) [203, 287] . This process, described in details for polyamines and polycations [197, 270, 288, 289] , should exist in vitro as in vivo. Other drugs, which are not able to link the coils intrahelical, usually don't induce collapsed DNA structures or micronuclei formation. Their mode of action is frequently privileged in the minor groove. Thus they would not be able to trigger micronuclei formation, too. Recently, a few of these ligands are even found as micronuclei preventing agents [290, 291] .
Hoechst33258, a bisbenzimidazole ligand, interacting preferentially in the minor groove, is described in the literature with such activity [292] . It causes chromosome decondensation in human cells [297] . Supplementary, its action significantly reduces the radiation-induced micronuclei-formation in vivo. This protective effect was observed up to 6 days after administration [292] . Other minor groove binding drugs, like netropsin, distamycin, and berenil with improved antineoplastic activity should be able to act protectively against micronuclei-formation, released from environmental contamination [293] . They could prevent large distortions in DNA [294] , as well as chromosome condensation. Likewise, their immediate interventions in DNA curvature processes are described [259, 295] . However, increased polyploidization often accompanies these effects [296] .
In topological SFM observations, Hoechst33258 was found complexed to nearly undisturbed DNA stretches [203] ; Fig (11) . Regular arrangements of DNA molecules (without drugs), visualized by SFM, often show strands parallelly formed on the substrate. SFM study of Hoechst33258/DNA complexes demonstrate that the induced DNA-stabilization at the minor groove site seems to be held without overall geometry disturbances [203, 287] .
In contrast to these groove-binding activities, adriamycin (doxorubicin) and bleomycin, both proven DNA damaging agents (and intercalators), intensify the micronuclei formation after treatment [284, 297, 298] . They are able to react intramolecularly with parts of the DNA strands inducing antineoplastic activities [299] . Some anthracycline-type drugs are also described to connect intrahelical bridges between two coils under formation of liquid crystalline structures [300] . Developing chelate-like complexes between DNA-strands or DNA-proteins increase their anticancer potential. Daunomycin, actinomycin D, and other intercalating agents were also positively tested for long-range interferences and intramolecular reactions with nucleic Fig. (10) . Hypothetical suprahelical arrangement of DNA complexed with several fluorenone molecules [203, 287] (stereo view, molecular modeling optimized by HyperChem 5.1, AMBER calculation). Fig. (11) . SFM study [203] of Hoechst 33258/DNA interaction -z-range 10 nm (contact mode, Digital Instruments Nanoscope III); a) DNA without drug, b) DNA/drug complex, ratio Hoechst33258 per base pair = 1 : 10.
acids [213, 301] . Consequently, the results indicate that DNA-binding agents influence the long-range packaging of nucleic acids into condensed, highly ordered tertiary structure. Those changes, so far only with light microscopy observed as micronuclei formations, could now be studied by nanoscopic techniques.
Furthermore, genotypic investigations of taxol have been done in the past years. Taxol is a potent chemotherapeutic substance, already known as inhibitor in microtubule formation. Mitotic index studies demonstrated that the effective drug (paclitaxel) blocked cells in the G2/M phase. In the study of M.G. Solis Recendez et al. [302] , a twofold higher concentration of paclitaxel in the nucleus than in the cytosol of a human lung tumor cell line was found. Increase in the number of micronucleated apoptotic cells, DNA fragmentation and a correlation with the p53 status are recently described phenomena of the cytotoxic paclitaxel effects [303, 304, 307] . Spectroscopic and thermodynamic studies of DNA/paclitaxel complexes show that the drug binds preferentially at homologous A/T-tracts [305, 306] . A molecular modeling study (calculated with HyperChem 5.1, AMBER method) of this interaction is shown in Fig. (12) . Paclitaxel is an optical active molecule with 11 chiral atoms in its structure; Fig. (4) [308] . It is assembled by a taxane-central part with several different side-chains. More hydrophilic groups as acetyl, and hydrophobic-like groups as the large C13-chain and the benzoate group, could interact at different parts of the DNA. Best optimization could be obtained by arranging the paclitaxel molecule in the major groove of the DNA. A high affinity of both acetyl groups to the phosphates in the backbone was observed. This complex only less influenced the cage-like globular structure of the taxanering systems. Multiple interaction possibilities are practicable with the bases pairs and the C13-chain and/or the C2 benzoate group. These lead to partly disturbances of the base arrangements while the strong backbone interaction could clamp the strands together. Best adaptation was found by using homologous A/Tsequences for calculations. A wider groove, displayed by other sequences, decreases the backbone interaction potential. Less stabilization was thermodynamically observed [306] . However, it seems that the backbone interaction of DNA/paclitaxel complexes could not only takes place inside the groove, but also perform long-range interactions intraor intermolecularly. SFM investigations of the DNA/paclitaxel complex show toroidal structures at the side of strand-like domains (Fig.  (13a) and (13b) ). By zooming in the strand-like regions, thick strands aligned to thinner strands become visible. Partly association of drug molecules to the strands could be an interpretation of the different thickness. The calculated DNA/drug complex fits the geometries of the shapes observed by SFM [309] .
Anyway, the amount of paclitaxel also seems to play a decisive role in the formation of the toroids. Their geometrical size varied only slightly between 280 and 320 nm diameter (Fig. (13c) ). It seems, that the DNA strands appear to be circumferentially wrapped around, thereby allowing for a close packing of the DNA strands without the need for sharp kinks or bends.
Generally, drug interaction can connect the randomly coiled DNA in aqueous solution and force the condensation into globular morphologies like nodes. Their induced anisotropic conditions could produce supracoiled structures into spherical shapes and may be the occasion for the increase in micronucleated cells [203, 213, 301, 303, 304, 310] .
In the past years, another class of molecules, which was already intensively investigated in the middle of the 20th century, became increasingly interesting. New results on the efficacy of algae in cancer prophylaxis, with "bis-basic" anthraquinone and fluorenone derivatives Fig. (13) . SFM study of DNA/paclitaxel interaction [309] (contact mode, Digital Instruments Nanoscope III, ratio taxol per base pair = 1 : 8); a) topographic overview of the complexes -toroids nearby strand-like structures observable, b) magnification of toroidal structures -three dimensional illustration, c) cross-section analysis of the toroids -dimensions: diameter between 280 -320 nm.
as active agents, are described [311, 312] . Their mode of DNA/interaction extends from intercalation, groovebinding, backbone interaction to overall influences on cell reactions. Depending on the side chains with favored peptide-like elements, they exhibit a broad range of activity [313] . For instance, they could influence the folding of the DNA [203] , induce cytokine-operation in general, and interferon-activities (endogenous reactions see also chapter 4.2.) in particular [314] [315] [316] [317] , and are capable of inhibiting both reverse transcriptases and telomerases [162, [317] [318] [319] [320] [321] [322] [323] ; see Fig. (10) . Their structures serve as model for some intercalators/base pair conceptions [131] .
Chemoprotection, e.g. by chlorophyll or coumarin and their derivatives, against mutagenic inducements is currently under investigation [324] . 7,8-Diacetoxy-4-methylcoumarin, with no prerequisite for oxidative biotransformations, has been reported to produce suicide inactivation of microsomal cytochrome P-450-catalysed formation of aflatoxin B1 (AFB1) [286, 325] . AFB1 binds to DNA and causes chromosomal aberrations in several cell-types [326] [327] [328] . Administration of the coumarin derivative to rats gives rise to significant inhibition of AFB1 binding to hepatic DNA in vivo, as well as AFB1-induced micronuclei formation in bone marrow cells. While those processes are interpreted as promising the antimutagenic potential of a drug, intense investigations in this direction are under performance [286, 329] .
Endogenous Reactions and Effective Drug Interrelations
It is well known that ailments are often induced by microorganisms (bacteria, viruses, protozoa and the like), by deterioration of tissues, by disorders of the endocrine glands, or by faulty metabolism. Genetic modifications might sometimes be caused of these injuries. Diseases are often replied with complex endogenous body reactions against the alien. Such defense mechanisms have the object to confine the injury to localized area and to prevent dangerous spreading. Frequently the nature is very successful with the defense and repair, but sometimes drug assistance is indispensable. So a short view inside the naturally defense organizations may give enlightenment how drug application can support, substitute or impede it. Chemical constituents of the blood, tissues and others are involved in a proven mesh of defense against toxins. Interacting in broad networks of implied actions, they adsorb the exogenous molecules and may carry them through the whole body. The invaded tissues reply with humeral and cellular immune response. Increased temperature and circulatory interactions are measurable effects accompanied with the production of cytokines. Especially the production of specific antibodies counteracts the effects of the invading germs and plays a crucial role in signal-induction processes and repulse stimulation.
Interferons, discovered some thirty years ago, are the most prominent cytokines for inducing the antiviral state in response to viral infections [330] . Soon it was believed that interferon was a single substance that had viral inhibitory effects. In the last decades, four major categories with broad biological effects have been elucidated [233, 275] . Subtypes of each have been identified since then. Another family of cytokines (colony-stimulation factors) consists of high-molecularweight glycoproteins like certain classes of interferons. Their mode of action is roughly defined as signal induction in hematopoietic regeneration [331, 332] , vaccination effects [333] , and neoplastic activities [334] . Therefore, it is intelligible to control and influence the cytokine factors with drugs. These interactions might also be performed with DNA as target for drug complexes. [335] [336] [337] .
As described above, a crucial role in physiological systems would be played by hydrogen bonds between the bases and the drugs, which are also responsible for manifold interactions of genetic transfer reactions. They are involved mostly at a selected site of action by bridging two potential donor/acceptor partners. The rigorous stereoselectivity and a geometrically limited frame make a drug, which interact via hydrogen bond, desirable selective acting on definite sites. Whether the H-bonding is a stabilizing or destabilizing interaction depends also on the solvent environment. Still, when these groups are accessible to the solvent, H-bonding between donors and acceptors must compete with water, which is in higher concentration, and the first partner during drug transport. When the donor/acceptor pairs have been set-up from interactions with water, as they would be in the interior of a globular protein or in the stacked bases of nucleic acids, frequently the formation of a hydrogen bonded network develops. The energy attributed to a hydrogen bond (1-12 kcal/mol) is significantly weaker than a typical covalent, electrostatic or coordinate bond, and is closer to the magnitude of the potentials for dipole-dipole interactions [22, 28, 63] .
At temperatures, normally encountered in living matter, bonds stronger than 10 kcal/mol are not likely to be broken by non-enzymatic means. The majority of drugs designed to affect physiological functions do not react with receptors or various biopolymers in our systems by the formation of essentially irreversible covalent bonds. Those few that do, are usually very toxic, long acting, and difficult to control safely from a clinical point of view. Pharmacodynamic agents, which interact much weaker in probably reversible bonding processes, are much more desirable. In other words, drugs that react thermodynamically very stable are not so easy to rid the entered tissue. Biomimetic carries of DNA vectors for somatic gene therapy, like viruses or liposomes, are presently one of the most common methods of gene delivery.
Cure and inoculation are important pharmacological subjects. Stimulation of endogenous reactions, e.g. the immune response, are desired effects where drug discovery work on. However, drug addiction created by replacement of endogenous reactions because of drug application is one of the well-known disadvantages exemplarily mentioned in drug efficacy. The expression level may vary depending on the disease and the general conditions of the patient. Sensible chemical-combined drug features are the content of new concepts arising in drug development.
V. OUTLOOK
DNA/drug interactions as discussed in this paper are a wide area for medicinal benefits, as well as disadvantages. As with all pharmaceutical therapies, the risk to benefit ratio of each agent needs to be considered carefully before embarking on extended courses of therapy. Here, we introduced some special features by reducing the kind of drugs to those with low molecular weight. Less-used (but promising) drugs at the side of well-inspected ones are explained in a supramolecular relationship. Long-range interactions, triggered by drugs, water, or surrounding ions, are of great importance in cellular processes.
As a consequence of the intimate connection between genotype and phenotype, understanding and exploiting of genetic differences in drug response have become a major growth area in pharmaceutical science. The vast amount of genetic informations and of their highly organized networks will be directed to specific targets, for instance, the genetics of the quite different enzymes of drug metabolism. So not only drugs which act directly on the genes are of medicinal interest, but also drugs interacting as "flexible keys" in dynamically adjustable interrelated meshs of receptors. Clinical studies of the inclusion of biological interactions were really promoted by the development of new techniques, especially analytic methods. Current medicinal benefit of drug application is preferentially devoted both to cure and inoculation of several diseases.
There are several challenges for drug development and DNA/drug research in future. Antibiotics, which leave the body, promote the development of drug-resistance bacteria. So the drug release in its unmodified structure has to be avoided. Fungi in the mucous membrane, as well as in the digestion tract play a decisive role in many diseases and influence intensively the immune system. Viruses, like influenza germ, are rapidly changed in their mimic. They attack epidemically every year human and animals in a new shape. We are just at the beginning of a bioinformational understanding between the response partners. These examples are only a few of a large number of others.
Nanostructural investigations at living cells are just practicable, since the analytical techniques are improved. In this field a great number of new experiences will illuminate our comprehension.
